AGIO$31.204.17%1.25
Agios Pharmaceuticals Inc (AGIO)
Date: 2026-11-03 16:00O: 30.20H: 31.64L: 30.06C: 31.20Vol: 684.9k
Agios Pharmaceuticals Inc stock is traded at $31.20, with a volume of 684,858. It is up +4.17% in the last 24 hours and down -1.89% over the past month. Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Previous Close:
$29.95
Open:
$30.20
24h Volume:
684,858
Relative Volume:
0.55
Market Cap:
$1.86B
Revenue:
$66.05M
Net Income/Loss:
-$422.60M
P/E Ratio:
-
EPS:
-$7.25
Net Cash Flow:
-$384.73M
1W Performance:
-18.15%
1M Performance:
-1.89%
6M Performance:
+13.21%
1Y Performance:
-22.00%
1-Day Range:
$0.00$0.00
1-Week Range:
$29.80$38.69
52-Week Range:
$22.24$46.00
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
Name
Agios Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
617-649-8600Address
88 SIDNEY STREET, CAMBRIDGE, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
Agios Pharmaceuticals Inc Stock (AGIO) Financials Data
Agios Pharmaceuticals Inc Stock (AGIO) Insider Trading
- SARAH GHEUENSOct 26 '26Officer
- Transaction
- Proposed Sale
- Cost
- $37.69
- #Shares
- 7,866
- Value ($)
- 296,468
- #Shares Total
- 0
- Gheuens SarahOct 26 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $37.69
- #Shares
- 7,866
- Value ($)
- 296,470
- #Shares Total
- 54,645
- Gheuens SarahOct 26 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $25.01
- #Shares
- 7,866
- Value ($)
- 196,729
- #Shares Total
- 62,511
- Gheuens SarahOct 22 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $25.01
- #Shares
- 500
- Value ($)
- 12,505
- #Shares Total
- 55,145
- Gheuens SarahOct 22 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $37.52
- #Shares
- 500
- Value ($)
- 18,760
- #Shares Total
- 54,645
- SARAH GHEUENSOct 22 '26Officer
- Transaction
- Proposed Sale
- Cost
- $37.52
- #Shares
- 500
- Value ($)
- 18,760
- #Shares Total
- 0
- Gheuens SarahOct 21 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $37.53
- #Shares
- 1,489
- Value ($)
- 55,882
- #Shares Total
- 54,645
- SARAH GHEUENSOct 21 '26Officer
- Transaction
- Proposed Sale
- Cost
- $37.53
- #Shares
- 1,489
- Value ($)
- 55,881
- #Shares Total
- 0
- Gheuens SarahOct 21 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $25.01
- #Shares
- 1,489
- Value ($)
- 37,240
- #Shares Total
- 56,134
- Gheuens SarahAug 04 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $30.48
- #Shares
- 30,000
- Value ($)
- 914,400
- #Shares Total
- 54,645
